Generic Name:- Fusidic Acid 2% w/w + Betamethasone Valerate 0.1% w/w
Manufactured By:- National Healthcare Pvt. Ltd.
Fusidic acid is prescribed for skin infections caused by germs called staphylococcal bacteria. Such infections include impetigo, infected cuts and grazes, and infected dermatitis.
Antibacterial belonging to fusidane group
Dose and Direction of Use
- For external topical cutaneous use
- Consideration should be given to official guidance on appropriate use of antibacterial agents
Mode of Action
Inhibits bacterial protein synthesis and is bacteriostatic in nature
Fusidic acid interferes with the function of elongation factor G (EF-G) sterically blocking the next stage of protein synthesis
- Primary infections - impetigo contagiosa, superficial folliculitis, sycosis barbae, paronychia and erythrasma
- Secondary skin infections - eczematoid dermatitis, infected contact dermatitis, and infected cuts/abrasions.
Hypersensitivity to the active substances or any of the excipients
Skin reactions such as pruritus and rash
Pain and irritation at the application site
Hypersensitivity and angioedema
Precautions and Warning
Pregnancy Category C
No effects during pregnancy are anticipated, since systemic exposure to topically-applied Fusidic Acid is negligible.
Extended or recurrent use increases risk of antibiotic resistance and contact sensitisation